Quoted Portfolio Companies
Unquoted Portfolio Companies
 
Friday, July 30, 2010

Purely Proteins - Biomedical collaboration with Asahi-Kasei

Purely Proteins Ltd (Cambridge, UK) today announced the initiation of a research collaboration to discover and develop new biomedical products with Asahi-Kasei Corporation (Tokyo, Japan). Aimed at expanding Asahi's already highly successful range of bio-materials, the project will develop new methods for purifying proteins using the proprietary ligand discovery systems developed at Purely Proteins.

Commenting on the program, Purely Proteins' Chief Executive Officer, Dr David Bailey, said, "We are delighted to be working with Asahi-Kasei, a world-class chemical company with unrivalled experience of developing advanced bioprocessing materials. This project presents both companies with major new opportunities for product development in an exciting area of biotechnology."

Commenting from Asahi-Kasei, External Technology Manager, Dr. Ogawa, said, "We have been very impressed with the capability of Purely Proteins' state-of-the-art science and technology. Purely Proteins' expertise in protein purification and ligand discovery will complement Asahi's in-house development programs and add significant value to our company's existing products."
 
ENDS 
 

 
Purely Proteins
Purely Proteins has been established to exploit the increasing need for and use of human proteins in human medical research. The company purifies suites of human proteins, as both drug targets and bio-therapeutics, using proprietary processes that ensure both high purity and biological activity. Purely Proteins also offers ligand screening services, backed by state-of-the-art informatics, to examine therapeutic targeting to these proteins.
 
Asahi-Kasei
Originally focused on the fibers and chemicals business sectors, today Asahi Kasei is growing through diversification into the fields of housing, health care and electronics. Asahi Kasei Corporation has seven constituent corporations - Asahi Kasei Fibers, Asahi Kasei Chemicals, Asahi Kasei Life & Living, Asahi Kasei Construction Materials, Asahi Kasei Homes, Asahi Kasei EMD and Asahi Kasei Pharma. Special emphasis is placed on R&D in the fields of electronics, health care, environmental preservation, and energy conservation.

Further information about the Asahi-Kasei Corporation can be found at http://www.asahi-kasei.co.jp

 


Published: 1st Dec 2004 - 10:11:11
Modified: 15th Dec 2005 - 11:11:41

 
 

Privacy Statement | Sitemap | © 2010 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.